Immunohistochemical Evaluation of Canine Pituitary Adenomas Obtained by Transsphenoidal Hypophysectomy

Vet Pathol. 2018 Nov;55(6):889-895. doi: 10.1177/0300985818784160. Epub 2018 Jun 20.

Abstract

Hypophysectomy specimens from 16 dogs with pituitary adenoma were evaluated with periodic acid-Schiff (PAS), reticulin, and immunohistochemistry for adrenocorticotrophic hormone (ACTH), melanocyte stimulating hormone (MSH), growth hormone (GH), and Ki-67. The reticulin network was obliterated in all adenomas. One adenoma expressed ACTH and GH. Eight corticotroph adenomas were basophilic to chromophobic, and PAS- and ACTH-positive. Seven melanotroph adenomas were distinguished from corticotroph adenomas by expression of MSH. Pituitary-dependent hypercortisolism was diagnosed in 5 of 8 dogs with corticotroph and 4 of 7 with melanotroph adenoma. Pituitary height/brain area (P/B) ratio was elevated in all dogs. Previous canine hypophysectomy studies suggested that melanotroph adenomas were larger and carried a worse prognosis than corticotroph adenomas; however, in this study, corticotroph adenomas in comparison to melanotroph adenomas were larger (median P/B ratio: 1.06 versus 0.76), more proliferative (median Ki-67 index: 9.47% versus 1.99%), and associated with shorter survival (median: 300 versus 793 days). Recommended immunohistochemistry for PAS-positive pituitary adenomas includes ACTH and MSH to distinguish corticotrophs from melanotrophs and Ki-67 for proliferation index.

Keywords: corticotroph adenoma; dog; immunohistochemistry; melanotroph adenoma; pituitary adenoma; pituitary-dependent hypercortisolism; transsphenoidal hypophysectomy.

MeSH terms

  • Adenoma / mortality
  • Adenoma / pathology
  • Adenoma / surgery
  • Adenoma / veterinary*
  • Animals
  • Dog Diseases / mortality
  • Dog Diseases / pathology*
  • Dog Diseases / surgery
  • Dogs
  • Female
  • Hypophysectomy / methods
  • Hypophysectomy / veterinary*
  • Male
  • Pituitary Gland / pathology
  • Pituitary Gland / surgery
  • Pituitary Neoplasms / mortality
  • Pituitary Neoplasms / pathology
  • Pituitary Neoplasms / surgery
  • Pituitary Neoplasms / veterinary*